Literature DB >> 4313727

Plasma metyrapone, adrenocorticotropic hormone, cortisol, and deoxycortisol levels. Sequential changes during oral and intravenous metyrapone administration.

W Jubiz, S Matsukura, A W Meikle, G Harada, C D West, F H Tyler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4313727

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  5 in total

1.  Pathophysiology of hypercortisolism in depression: pituitary and adrenal responses to low glucocorticoid feedback.

Authors:  B J Carroll; A Iranmanesh; D M Keenan; F Cassidy; W H Wilson; J D Veldhuis
Journal:  Acta Psychiatr Scand       Date:  2011-12-30       Impact factor: 6.392

2.  Site of stimulation of aldosterone biosynthesis by angiotensin and potassium.

Authors:  R D Brown; C A Strott; G W Liddle
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

3.  Circadian variation in plasma 17-hydroxyprogesterone in patients with congenital adrenal hyperplasia.

Authors:  S M Atherden; N D Barnes; D B Grant
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

4.  Mechanism of adrenal suppression by high-dose medroxyprogesterone acetate in breast cancer patients.

Authors:  H van Veelen; P H Willemse; D T Sleijfer; E van der Ploeg; W J Sluiter; H Doorenbos
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

5.  PREOPERATIVE TREATMENT WITH METYRAPONE IN PATIENTS WITH CUSHING'S SYNDROME DUE TO ADRENAL ADENOMA.

Authors:  Soraya Puglisi; Paola Perotti; Mattia Barbot; Paolo Cosio; Carla Scaroni; Antonio Stigliano; Pina Lardo; Valentina Morelli; Elisa Polledri; Iacopo Chiodini; Giuseppe Reimondo; Anna Pia; Massimo Terzolo
Journal:  Endocr Connect       Date:  2018-09-01       Impact factor: 3.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.